-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Complications including ischemic heart disease (IHD) aggravate the condition after SARS-CoV-2 infection
.
High lipoprotein (a) [Lp (a) ] levels IHD and thrombotic a strong risk factor for embolic events
Infected thrombus
Recently, a research article was published in the Journal of Internal Medicine, an authoritative journal in the field of internal medicine.
Researchers aim to assess whether SARS-CoV-2 infection changes the risk of high Lp(a) concentrations in predicting IHD or thromboembolic events
.
The researchers used the British Biobank to conduct a cohort study on data during the SARS-CoV-2 pandemic, and compared the baseline Lp(a) levels of SARS-CoV-2 positive patients and the population control group
.
The British Biobank has obtained ethical approval from the Northwest Multi-Center Research Ethics Committee (REC:11/NW/0382)
The relationship between Lp(a), SARS-CoV-2, IHD and thromboembolic events
The Lp(a) concentration of SARS-CoV-2 positive patients was similar to that of the control group
.
In population controls (n=435104) and SARS-CoV-2 positive patients (n=6937), as the concentration of Lp(a) increases, the risk of IHD increases
It can be seen that SARS-CoV-2 infection strengthens the correlation between high Lp(a) levels and IHD, but Lp(a) does not affect the risk of thromboembolic events
SARS-CoV-2 infection reinforces the correlation between high Lp(a) levels and IHD, but Lp(a) does not affect the risk of thromboembolic events
Original source:
Original source:Silvia Di Maio.
Lipoprotein (a) and SARS-CoV -2 infections: susceptibility to infections, ischemic heart disease and thromboembolic events in this message